Top Markets
Coin of the day
Science 37 Holdings, Inc. Science 37 Holdings, Inc.

Science 37 Holdings, Inc.

SNCE
Rang in Aktien #11780
Science 37 Holdings, Inc. specializes in providing innovative technology... Science 37 Holdings, Inc. specializes in providing innovative technology solutions to enable flexible and decentralized clinical trials. Their central platform facilitates modern, digital approaches to clinical research by bringing together all essential parties—including patients, trial investigators, nurses, coordinators, and sponsors—to streamline processes, centralize data generation, and standardize information. Furthermore, the platform integrates specialized networks of patient communities, telemedicine-enabled investigators, mobile nursing professionals, remote coordinators, and connected health devices, all vital for orchestrating adaptable clinical studies. Its highly configurable nature means it can support nearly any phase of a clinical study and a wide range of medical indications. Beyond its direct services, the company also licenses its proprietary, cloud-based technology platform to various life science institutions. Science 37 serves a diverse client base, including major and mid-sized pharmaceutical companies, Contract Research Organizations (CROs), academic institutions, and biotechnology firms. Established in 2014, Science 37 Holdings, Inc. is headquartered in Research Triangle Park, North Carolina.
Aktienkurs
$5.75
Zuletzt synchronisiert: 2024-03-22
Marktkapitalisierung
$659.57M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Science 37 Holdings, Inc. (SNCE)

Kategorie

P/S-Verhältnis für Science 37 Holdings, Inc. (SNCE)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Science 37 Holdings, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Science 37 Holdings, Inc. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber